ArticleDrug design, development and therapy2018

Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro.

Jennifer Bourn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.